Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, 44121, Ferrara, Italy.
University Hospital Psychiatry Unit, Integrated Department of Mental Health and Pathological Addiction, S. Anna University Hospital and Local Health Trust, Ferrara, Italy.
Curr Psychiatry Rep. 2022 Jun;24(6):325-335. doi: 10.1007/s11920-022-01339-y. Epub 2022 Jun 9.
Over the last 30 years, medical assistance in dying (MAiD) including euthanasia (EU) and physician-assisted death (or suicide, PAS) has become the center of a large debate, particularly when these practices have involved people with psychiatric illness, including resistant depression, schizophrenia, personality, or other severe psychiatric disorders. We performed a review utilizing several databases, and by including the most relevant studies in full journal articles investigating the problem of MAiD in patients with psychiatric disorders but not in physical terminal conditions (non-terminal, MAiD-NT).
Literature has shown that a small percentage of people with psychiatric disorders died by MAiD-NT in comparison with patients with somatic diseases in terminal clinical conditions (e.g., cancer, AIDS). However, the problem in the field is complex and not solved yet as confirmed by the fact that only a few countries (e.g., the Netherlands, Belgium, Luxemburg) have legalized MAiD-NT for patients with psychiatric disorders, while most have maintained the practices accessible only to people with somatic disease in a terminal phase. Also, how to make objective the criterion of irremediability of a mental disorder; how to balance suicide prevention with assisted suicide; how to avoid the risk of progressively including in requests for MAiD-NT vulnerable segments of the population, such as minors, elderly, or people with dementia, in a productive-oriented society, are some of the critical points to be discussed. The application of MAiD-NT in people with psychiatric disorders should be further explored to prevent end-of-life rights from contradicting the principles of recovery-oriented care.
在过去的 30 年中,协助死亡(MAiD),包括安乐死(EU)和医师协助死亡(或自杀,PAS),已成为一场大辩论的焦点,尤其是当这些做法涉及到患有精神疾病的人时,包括难治性抑郁症、精神分裂症、人格障碍或其他严重精神障碍。我们利用多个数据库进行了综述,并纳入了完整期刊文章中最相关的研究,这些研究调查了患有精神障碍但没有处于终末期躯体疾病(非终末期,MAiD-NT)的患者的 MAiD 问题。
文献表明,与处于终末期躯体疾病(如癌症、艾滋病)的患者相比,患有精神障碍的人通过 MAiD-NT 死亡的比例较小。然而,该领域的问题很复杂,尚未得到解决,这一点得到了证实,只有少数国家(如荷兰、比利时、卢森堡)将 MAiD-NT 合法化,适用于患有精神障碍的患者,而大多数国家仅允许处于终末期躯体疾病的患者获得这种做法。此外,如何使精神障碍无法治愈的标准客观化;如何在预防自杀和协助自杀之间取得平衡;如何避免在以生产为导向的社会中,将弱势群体(如未成年人、老年人或痴呆症患者)逐步纳入 MAiD-NT 请求的风险,都是需要讨论的关键点。应进一步探讨在精神障碍患者中应用 MAiD-NT,以防止生命末期的权利与以康复为导向的护理原则相矛盾。